Home > Insider Trading > Filing (0000899243-22-018500)

Filing Details

Accession Number:: 0000899243-22-018500
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-05-17 21:40:07
Reporting Period:: 2022-05-13

Accepted Time:: 2022-05-17 21:40:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1531177	Sight Sciences Inc.	SGHT	Surgical & Medical Instruments & Apparatus (3841)	800625749

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1870875	Staffan Encrantz	C/O Sight Sciences, Inc. 4040 Campbell Ave, Suite 100 Menlo Park CA 94025		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-05-13	1,802	$7.98	1,802	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2022-05-16	300,000	$8.20	301,802	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2022-05-17	250,000	$8.49	551,802	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,022,118	Indirect	See Footnote
Common Stock	632,456	Indirect	See Footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.91 to $8.00 per share, inclusive.
The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (4) and (5).
These shares are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.025 to $8.45 per share, inclusive.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.155 to $8.73 per share, inclusive.
These shares are held of record by Allegro Investment Fund, L.P. ("Allegro Investment Fund"). The Reporting Person is the President of Allegro Investment Inc., the investment manager of Allegro Investment Fund, and may be deemed to beneficially own the shares held by Allegro Investment Fund. The Reporting Person disclaims beneficial ownership of the shares held by Allegro Investment Fund (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any.
These shares are held of record by Allegro Investors LLC ("Allegro Investors"). The Reporting Person is a member of Allegro Investors and may be deemed to beneficially own the shares held by Allegro Investors.